scispace - formally typeset
Open AccessJournal ArticleDOI

Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives

Reads0
Chats0
TLDR
By far the most widespread mechanism of resistance to AGs is the inactivation of these antibiotics by AG-modifying enzymes, and an overview of these mechanisms is provided.
Abstract
Aminoglycoside (AG) antibiotics are used to treat many Gram-negative and some Gram-positive infections and, importantly, multidrug-resistant tuberculosis. Among various bacterial species, resistance to AGs arises through a variety of intrinsic and acquired mechanisms. The bacterial cell wall serves as a natural barrier for small molecules such as AGs and may be further fortified via acquired mutations. Efflux pumps work to expel AGs from bacterial cells, and modifications here too may cause further resistance to AGs. Mutations in the ribosomal target of AGs, while rare, also contribute to resistance. Of growing clinical prominence is resistance caused by ribosome methyltransferases. By far the most widespread mechanism of resistance to AGs is the inactivation of these antibiotics by AG-modifying enzymes. We provide here an overview of these mechanisms by which bacteria become resistant to AGs and discuss their prevalence and potential for clinical relevance.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal Article

High Genomic Diversity of Multi-Drug Resistant Wastewater

TL;DR: The genomic diversity of the indicator Escherichia coli in a German wastewater treatment plant is analysed and it is found that while treatment plants reduce the amount of bacteria released into the environment, they do not reduce the potential for antibiotic resistance of these bacteria.
Journal ArticleDOI

Graphene oxide and carbon dots as broad-spectrum antimicrobial agents – a minireview

TL;DR: Carbon-based materials, especially graphene oxide (GO) and carbon dots (C-Dots), are promising candidates for future applications against multidrug-resistant bacteria based on their strong capacity in disruption of microbial membranes.
Journal ArticleDOI

Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective.

TL;DR: Proficiency of bacteria to obtain resistance genes generated an unpleasant situation; a grave, but a lot unacknowledged, feature of resistance gene transfer.
Journal ArticleDOI

Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.

TL;DR: The modes of action of many ribosome-targeting antibiotics are described, the major resistance mechanisms developed by pathogenic bacteria are highlighted, and recent advances in structure-assisted design of new molecules are discussed.
Journal ArticleDOI

Antibiotic Resistance and the MRSA Problem

TL;DR: Besides development of new small molecules affecting cell viability, alternative approaches including anti-virulence and bacteriophage therapeutics are being investigated and may become important tools to combat staphylococcal infections in the future.
References
More filters
Journal ArticleDOI

Domain-domain interactions in the aminoglycoside antibiotic resistance enzyme AAC(6')-APH(2'').

TL;DR: Domain-domain interactions in AAC(6')-APH(2' ') offer a unique target for inhibitor strategies, as it is shown that their disruption simultaneously inhibits both activities >90%.
Journal ArticleDOI

Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.

TL;DR: Screening of a transposon insertion mutant library of Pseudomonas aeruginosa for increased susceptibility to paromomycin identified a number of genes whose disruption enhanced susceptibility of this organism to multiple aminoglycosides, including tobramycin, amikacin, and gentamicin.
Journal ArticleDOI

Identification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosis.

TL;DR: The continuous emergence and global spread of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis, the causative agent of TB, underscore the pressing clinical need for novel treatments of this deadly infectious disease and for new solutions to alleviate the resistance problem.
Journal ArticleDOI

Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?

TL;DR: Findings indicate the potential utility of plazomicin in combination with other antibiotics (mainly carbapenems) for the treatment of A. baumannii infections, including those caused bycarbapenem-resistant isolates.
Journal ArticleDOI

MexY-Promoted Aminoglycoside Resistance in Pseudomonas aeruginosa: Involvement of a Putative Proximal Binding Pocket in Aminoglycoside Recognition

TL;DR: The results presented here indicate that aminoglycosides are likely not captured and exported by this RND pump component in a unique manner but rather utilize a previously defined export pathway that involves a proximal drug-binding pocket that is also implicated in the export of nonaminogly cosides.
Related Papers (5)